echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > 1.7 billion injections!

    1.7 billion injections!

    • Last Update: 2021-12-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On November 22, the official website of NMPA showed that Simcere's bortezomib for injection passed the consistency evaluation of generic drugs


    Bortezomib is a proteasome inhibitor.


    According to data from Menet.


    Sales of terminal bortezomib in public medical institutions in China (unit: ten thousand yuan)

    Source: Mi Nei.


    With the review of Bortezomib for injection by Simcere Pharmaceuticals, there are currently 8 companies that have reviewed the product, including Chia Tai Tianqing, Yangtze River Pharmaceuticals, CSPC, Qilu Pharmaceuticals, and Hausen Pharmaceuticals


    Up to now, Simcere Pharmaceuticals has passed/deemedly passed the consistency evaluation of 16 varieties, including 5 anti-tumor drugs, including nedaplatin for injection, lenvatinib mesylate capsules, and pemetrexed for injection Disodium plug, bendamustine hydrochloride for injection and bortezomib for injection


    Data source: Mi Neiwang database, NMPA

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.